Allopurinol
- 1 lab in 1 country
- 1 finding against
- Funders: National Science and Technology Council and 2 more
- Humans2
Outcomes
1Frailty
no changein humans1
1 study
Frailty
no changein humans1
Allopurinol has no effect on frailty in humans.
Humansworsening frailty in nephrology patientsmedian follow-up of 3.0 yearsn = 19,389
International journal of medical sciences4 Aug 2026
Associations
1Frailty
downin humans1HR 0.65
1 study
Frailty
downin humans1HR 0.65
Allopurinol lowers the risk of frailty in humans (HR 0.65, 95% CI 0.46-0.93).
Humansin nephrology patients versus non-usersmedian follow-up of 3.0 yearsn = 19,389
International journal of medical sciences4 Aug 2026
Latest
2 in 12 monthsInternational Journal of Medical Sciences
Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients
Cohort study of 19,389 peoplePopulations